GPT and metabolic syndrome: Particularly, subjects with relatively higher ALT levels (>27 U/L) showed higher OR for MetS risk (8.03, CI: 7.06–9.12) than those with lower ALT levels (<15 U/L) among the ALT quartile groups after adjusting for confounding factors (i.e., age, sex, and education level) [36].